Inventor
HELSON LAWRENCE
US24 patents
⚠️ This page may combine multiple inventors who share the name “HELSON LAWRENCE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SIGNPATH PHARMA INC
14 patentsUS10357458B2Jul 23, 2019
Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current
SIGNPATH PHARMA INC16 citations93
US9682041B2Jun 20, 2017
Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current
SIGNPATH PHARMA INC21 citations93
US10258691B2Apr 16, 2019
Protective effect of DMPC, DMPG, DMPC/DMPG, EGPG, LysoPG and LysoPC against drugs that cause channelopathies
SIGNPATH PHARMA INC16 citations84
US10238602B2Mar 26, 2019
Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies
SIGNPATH PHARMA INC16 citations84
US10617639B2Apr 14, 2020
Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current
SIGNPATH PHARMA INC5 citations83
US10349884B2Jul 16, 2019
Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel
SIGNPATH PHARMA INC16 citations83
US10117881B2Nov 6, 2018
Protective effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC against drugs that cause channelopathies
SIGNPATH PHARMA INC16 citations83
US10449193B2Oct 22, 2019
Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies
SIGNPATH PHARMA INC13 citations82
US10532045B2Jan 14, 2020
Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel
SIGNPATH PHARMA INC6 citations71
US10485768B2Nov 26, 2019
Treatment for glioblastoma
SIGNPATH PHARMA INC4 citations63
US11806401B2Nov 7, 2023
Prevention of drug-induced atrio-ventricular block
SIGNPATH PHARMA INC0 citations61
US9170257B2Oct 27, 2015
Method and system for measuring the pharmacokinetics of liposomal curcumin and its metabolite tetrahydrocurcumin
SIGNPATH PHARMA INC1 citations51
US12004868B2Jun 11, 2024
Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel
SIGNPATH PHARMA INC0 citations50
US10739353B2Aug 11, 2020
Suppression of cytokine release and cytokine storm
SIGNPATH PHARMA INC0 citations38
HELSON LAWRENCE
3 patentsUS8753674B2Jun 17, 2014
Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current
HELSON LAWRENCE29 citations91
US8747890B2Jun 10, 2014
Intravenous infusion of curcumin and a calcium channel blocker
HELSON LAWRENCE16 citations82
US9393198B2Jul 19, 2016
Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders
HELSON LAWRENCE0 citations33